Thomas Paul Scherer (Thomas Scherer)

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 5

Top Topics

Magnetic Resonance

Randomized Controlled Trial

Prostate Cancer

Top Venues

Translational andrology and urology

BJU international

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas Paul Scherer, Cédric Poyet
Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer. Translational andrology and urology 13 (3) (2024)
Thomas Paul Scherer, Cédric Poyet
Prognostic properties of the baseline prostate-specific antigen value-insights from the European randomized study of screening for prostate cancer. Translational andrology and urology 13 (3) (2024)
Basil Kaufmann, Sharon Fischer, Alcibiade Athanasiou, Noémie Lautenbach, Anja Wittig, Uwe Bieri, Florian Alexander Schmid, Franz von Stauffenberg, Thomas Paul Scherer, Daniel Eberli, Michael A Gorin, Ralph Schiess, Cédric Poyet
Evaluation of Proclarix in the diagnostic work-up of prostate cancer. BJUI compass 5 (2) (2023)
Basil Kaufmann, Elisa Raess, Florian Alexander Schmid, Uwe Bieri, Thomas Paul Scherer, Moustafa Elleisy, Olivio F Donati, Niels J Rupp, Holger Moch, Michael A Gorin, Ashkan Mortezavi, Daniel Eberli
Focal Therapy with High-Intensity Focused Ultrasound for Prostate Cancer: Three Year Outcomes from a Prospective Trial. BJU international (2023)
Basil Kaufmann, Sharon Fischer, Alcibiade Athanasiou, Noémie Lautenbach, Anja Wittig, Uwe Bieri, Florian Alexander Schmid, Franz von Stauffenberg, Thomas Paul Scherer, Daniel Eberli, Michael A Gorin, Ralph Schiess, Cédric Poyet
Evaluation of Proclarix in the diagnostic work-up of prostate cancer. BJUI compass 5 (2) (2023)